ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 05/07/2024 at 22:00, 6 months 16 days ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF

published on 04/30/2024 at 18:05, 6 months 23 days ago

ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024

Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF

published on 04/30/2024 at 18:05, 6 months 23 days ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
PRESS RELEASE

published on 04/30/2024 at 18:00, 6 months 23 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24.
ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques

Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF

published on 04/05/2024 at 22:05, 7 months 18 days ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
BRIEF

published on 04/05/2024 at 22:05, 7 months 18 days ago

Abivax annonce la soumission de rapports financiers aux agences de régulation françaises et américaines

Abivax Maladies Inflammatoires Chroniques Rapports Financiers Les Organismes De Réglementation Annonce De Diffusion Web
PRESS RELEASE

published on 04/05/2024 at 22:00, 7 months 18 days ago

Abivax a déposé ses rapports financiers auprès des autorités de marchés financiers française et américaine
Abivax dépose ses rapports financiers auprès des autorités de marchés français et américaine, annonçant la disponibilité de ses documents pour l'année 2023

Biotechnologie Abivax Investisseurs Rapports Financiers Autorités De Marchés
PRESS RELEASE

published on 04/05/2024 at 22:00, 7 months 18 days ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF

published on 04/02/2024 at 08:35, 7 months 21 days ago

Abivax Reports 2023 Financial Results and Operational Update

Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
BRIEF

published on 04/02/2024 at 08:35, 7 months 21 days ago

Abivax publie ses résultats financiers 2023 et un point opérationnel

Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Introduction En Bourse Au Nasdaq

Published on 11/22/2024 at 23:55, 1 day 7 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 8 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 8 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 8 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 9 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 13 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 13 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 13 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 14 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 15 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 13 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 15 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 17 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 17 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 3 days ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News